|
| |
Current Topics in Pharmacology
Phcol 514
12:30 PM, Wednesday, January 26, 2000
Room T-530/530A HSC
Speaker: Michael Nolan
Topic: MS: Development of the Autoimmune Disease and Promising New
Treatments
References:
Wucherpfennig, K. W., and Strominger, J. L. (1995) Molecular mimicry in T
cell-mediated autoimmunity: viral peptides activate human T cell clones
specific for myelin basic protein. Cell 80:695-705.
Allegretta, M., Nicklas, J. A., Sriram, S., and Albertini, R. J. (1990) T
cells responsive to myelin basic protein in patients with multiple
sclerosis. Science 247:718-721.
Genain, C. P., Cannella, B., Hauser, S. L., and Raine, C. S. (1999)
Identification of autoantibodies associated with myelin damage in multiple
sclerosis [see comments]. Nat Med 5:170-175.
Goverman, J., Woods, A., Larson, L., Weiner, L. P., Hood, L., and Zaller,
D. M. (1993) Transgenic mice that express a myelin basic protein-specific
T cell receptor develop spontaneous autoimmunity. Cell 72:551-560.
Reviews:
Arnon, R. (1996) The development of Cop 1 (Copaxone), an innovative drug
for the treatment of multiple sclerosis: personal reflections. Immunol
Lett 50:1-15.
Conlon, P., Oksenberg, J. R., Zhang, J., and Steinman, L. (1999) The
immunobiology of multiple sclerosis: an autoimmune disease of the central
nervous system. Neurobiol Dis 6:149-166.
Steinman, L. (1996) Multiple sclerosis: a coordinated immunological attack
against myelin in the central nervous system. Cell 85:299-302.
Steinman, L. (1999) Assessment of animal models for MS and demyelinating
disease in the design of rational therapy. Neuron 24:511-514.
1999-2000 Journal Club Schedule
|